Efficacy and safety of decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin in newly diagnosed elderly patients with acute myeloid leukemia

PURPOSE: This prospective phase II, open label, study was designed to assess the efficacy and safety of D-CAG induction treatment for elderly patients with newly diagnosed AML. EXPERIMENTAL DESIGN: All patients in this study were treated with decitabine of 15 mg/m(2) for 5 days and G-CSF for priming...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jianyong, Chen, Yaoyu, Zhu, Yu, Zhou, Jianfeng, Xu, Yanli, Li, Yan, Yu, Kang, Pan, Ling, Wang, Jianmin, Ding, Jiahua, Gu, Jian, Zhou, Shanhua, Shi, Jinning, Hong, Ming, Xu, Ji, Pan, Liangqin, Duan, Limin, Zhang, Run, Zhang, Sujiang, Zhu, Huayuan, Lu, Hua, Liu, Peng, Qiu, Hongxia, Wu, Hanxin, Qian, Sixuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467448/
https://www.ncbi.nlm.nih.gov/pubmed/25749041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467448/
https://www.ncbi.nlm.nih.gov/pubmed/25749041

Ejemplares similares